Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Wiesława, Rudnicka"'
Autor:
Marek Fol, Marcin Włodarczyk, Magdalena Kowalewicz-Kulbat, Magdalena Druszczyńska, Krzysztof T. Krawczyk, Sebastian Wawrocki, Wiesława Rudnicka, Magdalena Chmiela
Publikováno v:
Vaccines, Vol 10, Iss 4, p 615 (2022)
Mycobacterium tuberculosis infections remain a global health problem in immunosuppressed patients. The effectiveness of BCG (Bacillus Calmette–Guérin), an anti-tuberculosis vaccine, is unsatisfactory. Finding a new vaccine candidate is a priority.
Externí odkaz:
https://doaj.org/article/178553232b664b539f9ec3729f49e7c7
Autor:
Wiesława Rudnicka, Michal Seweryn, Magdalena Druszczyńska, Grzegorz Kielnierowski, Sebastian Wawrocki
Publikováno v:
Saudi Journal of Biological Sciences, Vol 27, Iss 11, Pp 3035-3045 (2020)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
Background Differentiation of active pulmonary tuberculosis (TB) from non-mycobacterial community-acquired pneumonia (CAP) still remains a diagnostic challenge. Objective The study aimed to quantify the IL-18, IFN-γ, IL-18BP, IL-37, and IP-10 levels
Autor:
Agnieszka Matusiak, Adriana Vrba, Magdalena Kowalewicz-Kulbat, Magdalena Druszczyńska, Karolina Kasztalska, Dominik Strapagiel, Magdalena Chmiela, Wiesława Rudnicka
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 46, Iss 3, Pp 353-359 (2008)
Tuberculosis (TB) still remains the leading cause of mortality due to bacterial pathogen. The only currently available vaccine against TB, Bacille Calmette-GuĂŠrin (BCG) is at best credited with a 50% overall protective efficacy. Skin testing with
Externí odkaz:
https://doaj.org/article/bf893fe38e834075ab7e9a3441cef6e0
Autor:
JoĂŤl Pestel, Franck Biet, Stefan Donevski, Dominik Kaźmierczak, Magdalena Kowalewicz-Kulbat, Wiesława Rudnicka
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 46, Iss 2, Pp 153-157 (2008)
Mycobacterium bovis bacillus Calmette-GuĂŠrin (BCG) is a live vaccine that has been used in routine vaccination against tuberculosis for nearly 80 years. However, its efficacy is controversial. The failure of BCG vaccination may be at least partial
Externí odkaz:
https://doaj.org/article/d3de21fe3f364434a8ece0c1c25f0321
Autor:
Piotr Szpakowski, Franck Biet, Camille Locht, Małgorzata Paszkiewicz, Wiesława Rudnicka, Magdalena Druszczyńska, Fabrice Allain, Marek Fol, Joël Pestel, Magdalena Kowalewicz-Kulbat
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Tuberculosis remains an enormous global burden, despite wide vaccination coverage with the Bacillus Calmette-Guérin (BCG), the only vaccine available against this disease, indicating that BCG-driven immunity is insufficient to protect the human popu
Externí odkaz:
https://doaj.org/article/6b30fb8becee4beda854a648f0352d59
Autor:
Grzegorz Kielnierowski, Wiesława Rudnicka, Marcin Włodarczyk, Sebastian Wawrocki, Michal Seweryn, Magdalena Druszczyńska
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0225556 (2019)
PLoS ONE, Vol 14, Iss 12, p e0225556 (2019)
Background Currently, there are serious limitations in the direct diagnosis of active tuberculosis (ATB). We evaluated the levels of the IL-18/IL-37/IP-10 signalling complex proteins in Mycobacterium tuberculosis (M.tb)-specific antigen-stimulated Qu
Publikováno v:
Acta Biochimica Polonica.
Background: Polymorphisms in genes encoding cytokines are known to determine susceptibility to Mycobacterium tuberculosis (M.tb) infection. In particular, interleukin-18 (IL-18), an inducer of interferon-gamma (IFN-γ), playing an important role in a
Autor:
Michal Seweryn, Anna Pankowska, Wiesława Rudnicka, Magdalena Druszczyńska, Magdalena Kowalewska-Pietrzak, Sebastian Wawrocki
Publikováno v:
Pathogens
Volume 10
Issue 5
Pathogens, Vol 10, Iss 517, p 517 (2021)
Volume 10
Issue 5
Pathogens, Vol 10, Iss 517, p 517 (2021)
None of the currently used diagnostic tools are efficient enough in diagnosing Mycobacterium tuberculosis (M.tb) infection in children. The study was aimed to identify cytokine biosignatures characterizing active and latent tuberculosis (TB) in child
Autor:
Piotr Szpakowski, Camille Locht, Wiesława Rudnicka, Franck Biet, Krzysztof Krawczyk, Marek L. Kowalski, Slawomir Kosinski, Magdalena Kowalewicz-Kulbat
Publikováno v:
Vaccines
Vaccines, 2021, 9 (3), 14 p. ⟨10.3390/vaccines9030277⟩
Vaccines, MDPI, 2021, 9 (3), 14 p. ⟨10.3390/vaccines9030277⟩
Vaccines, Vol 9, Iss 277, p 277 (2021)
Volume 9
Issue 3
Vaccines, 2021, 9 (3), 14 p. ⟨10.3390/vaccines9030277⟩
Vaccines, MDPI, 2021, 9 (3), 14 p. ⟨10.3390/vaccines9030277⟩
Vaccines, Vol 9, Iss 277, p 277 (2021)
Volume 9
Issue 3
International audience; The only currently available anti-tuberculosis vaccine, Bacillus Calmette-Guérin (BCG), has been reported to also protect against unrelated diseases, including inflammatory diseases such as allergic asthma. Recombinant BCG st
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 146, Iss 6, Pp 700-707 (2017)
Indian Journal of Medical Research, Vol 146, Iss 6, Pp 700-707 (2017)
Tuberculosis (TB) remains an escalating problem worldwide. The current diagnostic methods do not always guarantee reliable diagnosis. TB treatment is a time-consuming process that requires the use of several chemotherapeutics, to which mycobacteria a